We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Solicits Feedback on End of EU Regulatory Reciprocity Pathway
UK Solicits Feedback on End of EU Regulatory Reciprocity Pathway
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is seeking public feedback on a plan that would end regulatory reciprocity between the UK and the EU for drug and device review and approvals.